注意偏向修正对心血管应激反应的影响
The Effect of Attentional Bias Modification on the Cardiovascular Stress Reactivity

作者: 段文杰 :重庆市文化发展研究会,跨文化与心理研究部,重庆;

关键词: 注意偏向注意偏向修正心血管应激反应Attentional Bias Attentional Bias Modification Cardiovascular Stress Reactivity

摘要:
尽管随着世界范围内现代医学的进步,对心血管疾病的诱发因素进行了大量、集中、深入的研究,但据WHO公布的数据说明心血管疾病的患病率在全球范围还是不断增高,因此这突出表明在整体医学不断发展的背景下,有必要采用生理–心理–社会医学模式来发现突破传统生化指标监测的新方法,在器质性疾病形成以前,起到预防、识别和干预有发展成心血管疾病风险的个人。以往研究表明,个体在面对压力源时,心血管会对压力产生相应反应,被称为心血管应激反应性,而这种长期的、不恰当的生理反应会最终导致器质性病变,即心血管疾病的产生。因此本文通过文献回顾,提出可在理论与实践两个维度进行探究的新命题:通过对个体注意偏向的修正改变其对负面信息(如压力源)的认知加工过程,从而降低个体在面对压力时产生的心血管应激反应性,最终达到减轻不恰当生理反应,降低发展成心血管疾病风险的目的。
Although with worldwide progress of modern medicine, there have been a lot of the centralized and deep researches about precipitating factors of cardiovascular disease, data published by WHO shows the morbidity rate of cardiovascular disease in the global scope has increased, so this highlights that under the background of the whole development of modern medicine, it is necessary to employ the physiological-psychological-social medical model to find a new method to break through traditional biochemical monitoring index, which can prevent, identify and intervene the individual who will develop into the risk of cardiovascular disease before the organic disease formed. Previous researches have suggested that, in the face of the pressure source, individual system will react to it, which is called cardiovascular stress reactivity, and this kind of long-term, inappropriate physiology reaction can eventually lead to organic lesion, namely the generation of cardiovascular disease. This paper is to utilize literature review to explore the following subjects in two dimensions of theory and practice: correct individual attention bias to change the cognitive process of negative information (such as the pressure source), so as to reduce the cardiovascular stress reactivity produced by individual when facing pressure, eventually to reduce improper physiology reaction and the risk of developing into cardiovascular disease.

文章引用: 段文杰 (2012) 注意偏向修正对心血管应激反应的影响。 亚洲心脑血管病例研究, 1, 10-14. doi: 10.12677/acrvm.2012.11003

参考文献

[1] C. Antonio, M. Enrico. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arteriosclerosis, Thrombosis, and Vascular Biology, 2004, 24: 816- 823.

[2] R. Gerald, A. Fahim and M. Tracey. Obesity, insulin resistance, and cardiovascular disease. Endocrine Reviews, 2004, 59(1): 207- 223.

[3] M. Claudia, T. Vin-cenzo and D. Alessandro. Genetic influences of adiponectin on insulin resistance, type2 diabetes, and cardiovascular disease. Diabetes, 2007, 56(5): 1198-1209.

[4] M. Reza, A. Khosrow. Hepatic insulin resis-tance, metabolic syndrome and cardiovascular disease. Clinical Bio-chemistry, 2009, 42(13-14): 1331-1346.

[5] E. Gunnar. Prevalence of cardiovascular risk factors and concentration of C-reactive protein in Type D personality persons without cardiovascular disease. European Journal of Preventive Cardiology, 2011, 18(3): 504-509.

[6] P. Mathieu, I. Lemieux and J. P. Després. Obesity, inflammation, and cardiovascular risk. Clinical Pharmacology & Therapeutics, 2010, 87(4): 407-416.

[7] Z. X. Wang, N. Tomohiro. Inflammation, a link between obesity and cardiovascular disease. Mediators of Inflamma-tion, 2010, 2010: 17.

[8] M. Elena, C. S. Crowson, H. M. Kremers, V. L. Roger, P. D. Fitz-Gibbon, T. M. Therneau and S E. Gabrie. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Clinical and Epidemiological Research, 2011, 70(3): 482-487.

[9] T. Lisman, S. H. Caldwell, A. K. Burroughs, P. G. Northup, M. Senzolo, R. T. Stravitz, A. Tripodi, J. F. Trotter, D. C. Valla and R. J. Porte. Hemostasis and thrombosis in patients with liver disease: The ups and downs. Journal of Hepatology, 2010, 53(2): 362-371.

[10] E. Brodin, T. Vikan, J. B. Hansen and J. Svartberg. Testosterone, hemostasis, and cardiovascular diseases in men. Seminars in Thrombosis and Hemosta-sis, 2011, 37(1): 87-94.

[11] S. Yende, G. D’Angelo, F. Mayr, J. A. Kellum, L. Weissfeld, A. M. Kaynar, T. Young, K. Irani and D C. An-gus. Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths. Hemostasis Markers and Pneumonia Mortality, 2011, 6(8): e22847.

[12] R. Pop-Busui, G. W. Evans, H. C. Gerstein, V. Fonseca, J. L. Fleg, B. J. Hoogwerf, S. Genuth, R. H. Grimm, M. A. Corson and R. Prineas. Effects of cardiac autonomic dysfunction on mortality risk in the action to control car-diovascular risk in diabetes (ACCORD) trial. Diabetes Care, 2010, 33(7): 1578-1584.

[13] P. Paolo, J. Stevo. The role of cardiac auto-nomic function in hypertension and cardiovascular disease. Current Hypertension Reports, 2007, 11(3): 199-205.

[14] X. Wang, X. Ding, S. Su, Z. Li, H. Riese, J. F. Thayer, et al. Genetic influences on heart rate variability at rest and during stress. Psychophysiology. 2009, 46(3): 458-465.

[15] N. Kupper, G. Willemsen, D. Posthuma, D. De Boer, D. Boomsma and E. J. De Geus. A genetic analysis of ambulatory cardio-respiratory coupling. Psychophysiology, 2005, 42(2): 202-212.

[16] N. Kupper, G. Willemsen, D. I. Boomsma and E. J. De Geus. Heritability of indices for cardiac contractility in ambulatory recordings. Journal of Cardiovascular Electrophysiology, 2006, 17(8): 877-883.

[17] Andrew, H, Kemp, Quintana D S, Gray M A. Is heart rate variability reduced in depression without cardiovascular disease? Biological Psychiatry, 2011, 69(4): e3-e4.

[18] A. C. Phillips. Blunted cardiovascular reactivity relates to depression, obesity, and self-reported health. Biological Psy-chology, 2011, 86(2): 106-113.

[19] A. J. Grippo, A. K. Johnson. Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from pre-clinical disease models. Stress, 2009, 12(1): 1-21.

[20] P. F. Sullivan, M. C. Neale and K. S. Kendler. Genetic epidemiology of major depres-sion: Review and meta-analysis. American Journal of Psychiatry, 2000, 157(10): 1552-1562.

[21] A. M. Thompson, T. Hu, C. L. Eshelbrenner, K. Reynolds, J. He and L. A. Bazzano. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension. Journal of the American Medical Association, 2011, 305(9), 913-922.

[22] Buxtona, O M, Marcelli E. Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Social Science & Medicine, 2010, 71(5): 1027-1036.

[23] D. M. Mannino, D. Thorn, A. Swensen and F. Holguin. Prevalence and outcomes of diabe-tes, hypertension and cardiovascular disease in COPD. European Res-piratory Journal, 2008, 32(4): 962-969.

[24] C. M. Champagne. Magnesium in hypertension, cardiovascular disease, metabolic syn-drome, and other conditions: A review. Nutrition in Clinical Practice, 2008, 23(2): 142-151.

[25] A. G. Olsson. Laropiprant plus niacin for dyslipidemia and prevention of cardiovascular disease. Expert Opinion on Pharmacotherapy, 2010, 11(10): 1715-1726.

[26] M. J. Chapmana, J. S. Redfernc, M. E. McGovernd and P. Giral. Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk. Pharmacology & Therapeutics, 2010, 126(3): 314-345.

[27] J. Genest, et al. Canadian cardiovascular society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardio-vascular disease in the adult—2009 recommendations. Canadian Jour-nal of Cardiology, 2009, 25(10): 567- 579.

[28] D. Maccubbin, et al. Flushing profile of extended-release niacin/laropiprant versus gradu-ally titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease. The American Journal of Cardiology, 2009, 104(1): 74-81.

[29] C. J. Lavie, R. V. Milani and H. O. Ventura. Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss. Journal of the American College of Cardi-ology, 2009, 53(21): 1925-1932.

[30] S. S. Martin, A. Qasim and M. P. Reilly. Leptin resistance: A possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology, 2008, 52(15): 1201-1210.

[31] G. M. Reaven. Insulin resistance: The link between obesity and cardiovascu-lar disease. Medical Clinics of North America, 2011, 95(5): 875-892.

[32] 姚如珍. 人格特征与心身疾病[J]. 临床心身疾病杂志, 2006, 12(1).

[33] F. Mols, J. Denollet. Type D personality in the general population: A systematic review of health status, mechanisms of dis-ease, and work-related problems. Mols and Denollet Health and Qual-ity of Life Outcomes, 2010, 8: 9.

[34] N. Kupper, J. Denollet, E. J. De Geus, D. I. Boomsma and G. Willemsen. Heritability of type-D person-ality. Psychosomatic Medicine, 2007, 69(7): 675-681.

[35] 瞿云中,黄彦科, 姚树桥. D型人格量表用于心血管病人群的信效度[J]. 中国临床心理学杂志, 2009, 17(4): 452-456.

[36] 张勇, 张亚林, 邹韶红, 李恒芬. D型人格量表在儿童少年情绪障碍患者中的信度效度研究. 中国行为医学科学, 2006, 15(8): 757-759.

[37] T. W. Kamarck, W. R. Lovallo. Cardiovascular reactivity to psychological challenge: Conceptual and measurement considerations. Psychosomatic Medicine, 2003, 65(1): 9-21.

[38] A. Mathews, C. MacLeod. Cognitive ap-proaches to emotion and emotional disorders. Annual Review of Psy-chology, 1994, 45(1): 25-50.

[39] A. Mathews, C. MacLeod. Cogni-tive vulnerability to emotional disorders. Annual Review of Clinical Psychology, 2005, 1: 167- 195.

[40] A. C. Puliafico, P. C. Kendall. Threat-related attentional bias in anxious youth: A review. Clinical Child and Family Psychology Review, 2006, 9(3): 162-180.

[41] T. Dalgleish, F. N. Watts. Biases of attention and memory in disorders of anxiety and depression. Clinical Psychology Review, 1990, 10(5): 589-604.

[42] L. Sharpe, B. F. Dear and L. Schrieber. Attentional biases in chronic pain associated with rheumatoid arthritis: Hypervigi-lance or difficulties disengaging? The Journal of Pain: Official Journal of the American Pain Society, 2009, 10(3): 329.

[43] E. Smeets, A. Roefs, E. Van Furth and A. Jansen. Attentional bias for body and food in eating disorders: Increased distraction, speeded detection, or both? Behaviour Research and Therapy, 2008, 46(2): 229-238.

[44] S. Hayes, C. R. Hirsch, G. Krebs and A. Mathews. The effects of modify-ing interpretation bias on worry in generalized anxiety disorder. Be-haviour Research and Therapy, 2010, 48(3): 171- 178.

[45] C. MacLeod, E. Rutherford, L. Campbell, G. Ebsworthy and L. Holker. Selective attention and emotional vulnerability: Assessing the causal basis of their association through the experimental manipulation of attentional bias. Journal of Abnormal Psychology, 2002, 111(1): 107-123.

[46] A. M. Waters, J. S. Valvoi. Attentional bias for emo-tional faces in paediatric anxiety disorders: An investigation using the emotional go/no go task. Journal of Behavior Therapy and Experimen-tal Psychiatry, 2009, 40(2): 306-316.

[47] Y. Bar-Haim, D. Lamy, L. Pergamin, M. J. Bakermans-Kra- nenburg and M. H. Van IJzendoorn. Threat-related attentional bias in anxious and nonanxious individuals: A meta-analytic study. Psychological Bulletin, 2007, 133(1): 1-24.

[48] J. M. Cisler, E. H. W. Koster. Mechanisms of attentional biases towards threat in the anxiety disorders: An integrative review. Clinical Psychology Review, 2010, 30(2): 203-216.

分享
Top